WallStreetZenWallStreetZen

NASDAQ: SLNO
Soleno Therapeutics Inc Stock Ownership - Who owns Soleno Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Soleno Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Bhatnagar AnishCHIEF EXECUTIVE OFFICER2024-04-017,597$41.67
$316.54kSell
Kristen YenOfficer title Senior Vice President Clinical Operations2024-04-011,330$41.12
$54.69kSell
Kristen YenOfficer title Senior Vice President Clinical Operations2024-04-01888$41.67
$37.00kSell
James H. MacKanessCHIEF FINANCIAL OFFICER2024-04-012,071$41.67
$86.29kSell
James H. MacKanessCHIEF FINANCIAL OFFICER2024-04-013,104$41.12
$127.65kSell
Patricia C. HiranoOfficer title Senior Vice President Regulatory Affairs2024-04-011,330$41.12
$54.69kSell
Patricia C. HiranoOfficer title Senior Vice President Regulatory Affairs2024-04-01888$41.67
$37.00kSell
Bhatnagar AnishCHIEF EXECUTIVE OFFICER2024-04-0111,383$41.12
$468.10kSell
Kristen YenOfficer title Senior Vice President Clinical Operations2024-01-25397$48.30
$19.18kSell
Bhatnagar AnishCHIEF EXECUTIVE OFFICER2024-01-252,527$48.30
$122.05kSell

1 of 9

SLNO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SLNO insiders and whales buy or sell their stock.

SLNO Shareholders

What type of owners hold Soleno Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Andrew Sinclair87.26%28,325,204$1.11BInsider
Abingworth LLP76.99%24,991,874$983.18MInsider
Edgar Engleman70.10%22,756,018$895.22MInsider
James Walter Glasheen26.09%8,470,180$333.22MInsider
Vivo Opportunity LLC25.93%8,418,093$331.17MInsider
Vivo Capital LLC25.93%8,418,093$331.17MInstitution
Stuart J. Collinson22.34%7,252,746$285.32MInsider
Forward V Associates LLC22.10%7,173,976$282.22MInsider
Perceptive Advisors LLC15.46%5,018,997$197.45MInsider
Vivo Ventures V LLC11.33%3,678,864$144.73MInsider

1 of 3

SLNO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SLNO20.62%79.38%Net BuyingNet Selling
PHVS77.92%0.00%
VRNA10.44%55.94%Net SellingNet Selling
LGND14.99%85.01%Net SellingNet Buying
XNCR66.74%33.26%Net BuyingNet Selling
View Top Biotech Stocks

Soleno Therapeutics Stock Ownership FAQ

Who owns Soleno Therapeutics?

Soleno Therapeutics (NASDAQ: SLNO) is owned by 96.76% institutional shareholders, 372.61% Soleno Therapeutics insiders, and 0.00% retail investors. Andrew Sinclair is the largest individual Soleno Therapeutics shareholder, owning 28.33M shares representing 87.26% of the company. Andrew Sinclair's Soleno Therapeutics shares are currently valued at $1.06B.

If you're new to stock investing, here's how to buy Soleno Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.